Delivery Order SPE2DB20D2104-SPE2DB24FS29T
- Not listed
- This federal contract award, valued at $42,290.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of KEPPRA 1,000 MG TABLET 60S, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
- This federal contract award, valued at $14,083.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KEPPRA 250 MG TABLET 120S, a prescription medication. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award, valued at $81,267.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KEPPRA 1,000 MG TABLET 60S, a pharmaceutical product, and has an ultimate completion date of March 27, 2025. The contract type is a Delivery Order with a Firm Fixed Price pricing mechanism. This award is not designated as a set-aside contract....
- This federal contract award is a Delivery Order with a Firm Fixed Price contract type, valued at $22,470.38. It was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of 4,563,155,026 units of KEPPRA 1,000 MG TABLET 60S, a pharmaceutical product, with a completion date of December 21, 2023. The contract award is not designated as a set-aside....
- This federal contract award, valued at $28,464.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of KEPPRA 500 MG TABLET 120S, a pharmaceutical product, with a completion date of July 11, 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is the prime contractor and holds a larger Indefinite Delivery...
- This federal contract award, valued at $28,914.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Keppra 1,000 mg tablets, a medication used to treat epilepsy. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the...
- This federal contract award, valued at $5,018.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KEPPRA 500 MG TABLET 120S, a prescription medication, to support military healthcare programs. The award is a delivery order under an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,925.53 firm-fixed price delivery order is for the supply of Keppra 500 mg tablets, a medication used for the treatment of epilepsy. The contract has an ultimate completion date of November 16, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of KEPPRA 100 MG/ML ORAL SOLN 473ML, a medication used for the treatment of seizures. The contract is a firm fixed-price delivery order with a ceiling value of $1,865.72 and an ultimate completion date of February 25, 2025. The contract is not designated as a set-aside. AmerisourceBergen...
- This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), valued at up to $999,999,999 through December 2025. The delivery order is for the pharmaceutical product Keppra 250 mg tablet, with a ceiling value of $1,861.87 and an ultimate completion date of August 27, 2024. Amerisourcebergen, a major pharmaceutical distributor, will provide this critical...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FS29TDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,221.90, is a delivery order for the supply of KEPPRA 250 MG TABLET 120S, a medication used for the treatment of epilepsy. The contract has an ultimate completion date of January 31, 2024 and utilizes a firm fixed-price pricing type. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/30/24 |